𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Sixth International Conference on the Long-Term Complications of Treatment of Children and Adolescents for Cancer

✍ Scribed by Green, Daniel M. ;D'Angio, Giulio J.

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
25 KB
Volume
36
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long term use of megestrol acetate by ca
Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes
✍ Susan K. Quella; Charles L. Loprinzi; Jeff A. Sloan; Nancy L. Vaught; Wanda L. D πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 1 views

## Background: The incidence of hepatoblastoma in children of very low birth weight (< 1500 g) is increasing in japan. the authors reviewed surgical and pathologic aspects of the tumor to clarify the characteristics of the patients. ## Methods: Fifteen patients (9 boys and 6 girls) who were diagn

The toxicity and long-term efficacy of n
The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer
✍ Mingzhu Yin; Haiyu Zhang; Huiyan Li; Xia Li; Yunduo Liu; Xiuwei Chen; Ge Lou; Ka πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

## Abstract ## Background The use of neoadjuvant chemotherapy (NACT) for the treatment of locally advanced cervical cancer (LACC) remains controversial. In current clinical practice, platinum‐based chemotherapy is the major option for patients with LACC. However, serious adverse events have been r

Comparison of long-term outcome of child
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group
✍ Sposto, Richard ;Meadows, Anna T. ;Chilcote, Robert R. ;Steinherz, Peter G. ;Kje πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 163 KB

## Abstract ## Background Early Children's Cancer Group (CCG) trials indicated that the cyclophosphamide, vincristine, methotrexate, and prednisone (COMP) regimen was superior to the LSA~2~L~2~regimen for non‐lymphoblastic (NLB) non‐Hodgkin lymphoma (NHL). Studies by other groups suggested that ad